Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots

Completed · Phase 4

Conditions studied: Hyperpigmentation

In brief

The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.

Key facts

Study ID

NCT01149876

Run by

Massachusetts General Hospital

People needed

80

Starts

2010-06-01

Expected to finish

2011-12-01

Last updated by the study team

2014-11-06

Who can join

Age: 25 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Able to understand and sign informed consent.
• Able to complete study and comply with study procedures.
• Caucasian female ages 25-55.
• Presence of photodamage and lentigines of II-III on the Glogau Photoaging
• Must be willing to avoid laser and light treatments, treatments with filler, chemical peels, microdermabrasion, Botox or any other cosmetic treatment to the face during the duration of the study.
• Must be willing to avoid changing topical moisturizers and cosmetics during the study.
• Able to stop any alpha or beta hydroxy acids, topical retinol or retinoid derivatives, topical antioxidants, or any topical product that may interfere with the study 2 weeks prior to the study.

You may not qualify if…

• Cosmetic treatment of face, such as laser or light treatment, filler, Botox, microdermabrasion, or chemical peels 6 months prior to study or during study.
• Current smoker.
• Pregnant, nursing, or planning to become pregnant during study.
• Currently taking drugs including oral retinoids or any other medication with a known clinically significant drug interaction with topical tretinoin.
• Known hypersensitivity to retinoids. History of severe retinoid dermatitis.
• History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study.
• Concurrent participation in another clinical study or participation 30 days prior to enrollment that includes exposure to an investigational drug that would interfere with this study.
• Any disease or condition which would interfere with study participation or unduly increase risk.
• Presence of an electrically sensitive support system such as a pacemaker.
• Known history of epilepsy.
• Presence of metal implants or metal braces on teeth.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.